Navigation Links
CROI -- Day 2: Selected highlights of NIH-supported research
Date:2/28/2011

The 18th Conference on Retroviruses and Opportunistic Infections is taking place at the Hynes Convention Center in Boston from February 27 through March 2. Day two of this major HIV/AIDS research conference included the following selected presentations from scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

HIV/TB Co-Infection

Diane Havlir, M.D., of the University of California, San Francisco School of Medicine, presented findings from an international clinical trial known as ACTG 5221, or STRIDE, in persons co-infected with HIV and tuberculosis (TB). The study compared the risks and benefits of immediate versus early antiretroviral therapy (ART) in HIV-infected patients being treated for TB. The findings further illuminate the delicate balance of starting HIV treatment in individuals who also have TB, as HIV treatment in this context can sometimes cause a severe immune inflammatory syndrome. For HIV/TB co-infected patients who have fewer than 250 CD4+ T cells per cubic millimeter (mm3), the researchers found that beginning ART within 2 weeks (immediate) after beginning TB treatment does not reduce the risk of AIDS or death compared with starting ART 8 to 12 weeks later (early). However, in the subset of individuals with fewer than 50 CD4+ T cells/mm3a state of severe immune system damagestarting ART within 2 weeks after beginning TB treatment reduces the risk of AIDS or death significantly.

Microbicide Research

Peter Anton, M.D., of the David Geffen School of Medicine at the University of California, Los Angeles, presented findings from the Phase I clinical trial known as RMP-02/MTN-006, a placebo-controlled study comparing rectally applied 1% tenofovir gel to oral tenofovir disoproxil fumarate. In an earlier landmark study, tenofovir gel protected 39 percent of female participants from HIV infection when applied vaginally. In fi
'/>"/>

Contact: Laura Sivitz Leifman
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Brigham and Womens Hospital selected to participate in Medicare imaging demonstration project
2. Paper by Rhode Island Hospital physician selected among best of 2010 by JACR
3. UCLA selected by Homeland Security to help establish guidelines for firefighter health and safety
4. Selected cells from blood or bone marrow may provide a route to healing blood vessels
5. Kennedy Krieger Institutes Dr. Paul Lipkin selected for national health policy fellowship
6. Neuxpower Selected as 2010 Emerging Technology Vendor by CRN Magazine
7. Renowned Psychiatrist, Lyubov Y Gorelik, M.D., is selected to represent New York in The Leading Physicians of the World
8. MetricStream Selected by SunTrust for Enterprise-Wide GRC
9. MBA HealthGroup Selected as Preferred Partner by VITL
10. BMI of Texas Selected to Participate in Lap-Band Total Care™ Out of Towner Network
11. Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... Indiana (PRWEB) March 01, 2015 ... statewide Network Service Provider, announces NewWays Networking, LLC ... “By working with IFN, NewWays is well ... meet client’s demand for Internet bandwidth in rural ... , According to Cory Childs IFN Enterprise ...
(Date:2/28/2015)... Malaysia (PRWEB) February 28, 2015 The ... all across Malaysia into one platform and gears towards ... , A series of group talks in smaller ... like Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, ... and raise awareness of Malaysian youths. , ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... February 28, 2015 Vancouver personal injury lawyers ... claims are affected by time limits. They stated that in ... person’s claim or even nullify it. Many a time, delays ... a client’s rights under BC law. As a result, experts ... by accidents should consult a personal injury lawyer in order ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be ... Materials Show, an annual, premier sustainable building event in ... top manufacturers of the latest building products, services and ... and manufactured by Pioneer Millworks from their Oregon and ... restaurants, hotels, retailers, and corporate offices. Nichibi Global ...
Breaking Medicine News(10 mins):Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... data from previously completed withdrawal to monotherapy studies for ... studies, obviating the need for placebo/pseudo-placebo trials to demonstrate ... this study are now available online in Epilepsia ... the International League Against Epilepsy. According to a ...
... is available in French . Montreal, ... Heart Institute (MHI) has shown unexpectedly that living with children ... with 756 participants and led by Dr. Simon L. Bacon, ... the study assessed the impact of social networks on exercise, ...
... lives of infants and children with developmental disabilities will ... Developmental Disabilities Research Center (WUIDDRC). The center, established ... National Institutes of Health (NIH), will focus on research ... emphasis will be placed on clinical and translational research ...
... 2010 - Janice Morse, RN, PhD, FAAN, a professor ... inducted into the newly created Sigma Theta Tau International ... researchers who have achieved long-term, broad national and/or international ... research has impacted the profession and the people it ...
... the skin cancer melanoma appear different in Florida than ,from ... non-Hispanic black women but lower rates among Hispanic women, according ... of Dermatology, one of the JAMA/Archives journals. "In ... than that of any other cancer," the authors write as ...
... , MONDAY, July 19 (HealthDay News) -- Children conceived using ... than do children who were conceived naturally, new research shows. ... increased by 42 percent for Swedish youngsters conceived with IVF, ... "We found a roughly 50 percent increased risk for cancer ...
Cached Medicine News:Health News:FDA accepts historical controls for epilepsy monotherapy studies 2Health News:FDA accepts historical controls for epilepsy monotherapy studies 3Health News:Concordia researcher leads study that finds kids reduce physical activity for heart patients 2Health News:Developmental disabilities center established at Washington University 2Health News:U of U's Janice Morse inducted into International Nurse Researcher Hall of Fame 2Health News:Melanoma rates among minorities in Florida differ from national trends 2Health News:Study Suggests Higher Cancer Rate Among IVF Babies 2Health News:Study Suggests Higher Cancer Rate Among IVF Babies 3
(Date:2/27/2015)... , Feb. 27, 2015 Roughly three-quarters ... very confident substituting an interchangeable biosimilar for its ... the same nonproprietary name, according to a survey ... (AMCP,s) Journal of Managed Care & Specialty ... 25 percent of pharmacists would feel as confident ...
(Date:2/27/2015)... Feb. 27, 2015  Pomerantz LLP is investigating claims ... or the "Company") (NASDAQ: VTAE ).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On February 27, 2015, the Company ...
(Date:2/27/2015)... February 27, 2015 ... dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF - ...     Vectorious ... nuovo sistema per il monitoraggio cardiaco destinato a ... oggi di aver concluso una raccolta di finanziamenti ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... FREMONT, Calif., Nov. 19 Quark Pharmaceuticals, Inc., the leader ... its siRNA R&D platform based programs have met clinical development ... a new IND opened for ocular neuroprotection drug candidate QPI ... has completed enrollment in a Phase 2 study of PF-4523655 ...
... Nov. 19 Radiall and Integral Process will collaborate in ... agreement to confirm this new alliance. , Radiall has a ... time, the company has established relationships with major players in ... , Integral Process is a key supplier of interconnect ...
Cached Medicine Technology:Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 2Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 3Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 4Radiall and Integral Process Sign Agreement 2
... with the MAMMOTOME® HH (Hand ... invasive procedure using ultrasound imaging ... images to locate breast abnormalities, ... and map the area you ...
... A biopsy with the MAMMOTOME® ... effective, minimally invasive procedure using ... management.,Using computer-generated images to locate ... accurately pinpoint and map the ...
... occlusive wrap than VICRYL knitted mesh. Especially ... be contained. Predictable absorption. Polyglactin 910 has ... nonpyrogenic. ,VICRYL (polyglactin 910) woven mesh is ... glycolide and lactide, derived respectively from glycolic ...
... Line Reinforcement Material is a safe, ... air leaks and as such, the ... biocompatible, ePTFE material requires no pretreatment ... load and fire and the material's ...
Medicine Products: